
zzso zzso zzso requires the optimal integration of multiple zzso including an efficient delivery system, a disease indication that is appropriate for zzso therapy, and a potent and nontoxic zzso against a robust therapeutic zzso Although all currently available delivery systems have limitations, it is important to recognize that a careful selection of the disease indication, therapeutic target, and zzso zzso could partially compensate for deficiencies associated with the delivery system and makes it possible to advance a therapeutic zzso zzso In this study, we present the development of zzso zzso for zzso zzso using an integrated approach, including the development of an efficient zzso zzso delivery system, the identification of a robust therapeutic target that does not trigger liver toxicity upon target zzso and the selection of potent and zzso zzso molecules against the zzso The resulting zzso zzso zzso produced significant zzso efficacy in zzso zzso zzso models, and, thus, represent a promising starting point for the development of zzso zzso for zzso zzso 

